Research and Markets (http://www.researchandmarkets.com/research/xvt9hk/cancer) has announced the addition of the "Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016" report to their offering.

The Report, Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

Key Topics Covered:

  • A snapshot of the global Market and Phase III therapeutics scenario for Cancer Pain.
  • A review of the marketed products under prescription for Cancer Pain, regulatory information and marketing status.
  • Coverage of global patent coverage and detailed commentaries on the US patent challenges.
  • Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
  • Product profiles for marketed products for Cancer Pain with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

Benefits of this Report:

  • Evaluate the marketing status and exclusivity details of Cancer Pain key products to exploit opportunities for generic drug development opportunities.
  • Identify and understand important and diverse types of therapeutics under Phase III development for Cancer Pain.
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Cancer Pain.
  • API intelligence over marketed drugs for Cancer Pain and gaining primary intelligence over active ingredients manufacturers across the globe.
  • API intelligence over leading Phase III Pipeline drugs.

Report Structure:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Cancer Pain

7. Phase III Drugs for Cancer Pain

8. Discontinued Drugs for Cancer Pain

9. Appendix

10. Methodology

11. Consulting Services

12. Contact Us

13. Disclaimer

For more information visit http://www.researchandmarkets.com/research/xvt9hk/cancer